TL;DR
Measles cases in the United States have surged to their highest level in 35 years, and NIH Director Dr. Jay Bhattacharya has publicly declared, "I trust the science" on childhood vaccines. This statement matters because it signals a potential shift in federal health messaging at a moment when vaccination rates are slipping and public health officials are scrambling to contain the worst outbreak since the pre-vaccine era.
What Happened
Dr. Jay Bhattacharya, the director of the National Institutes of Health, broke his public silence on the escalating measles crisis with a direct endorsement of childhood vaccines, telling CBS News, "I trust the science." His remarks come as the Centers for Disease Control and Prevention confirmed that measles cases have climbed to their highest levels in 35 years, with outbreaks now spreading across multiple states and straining pediatric hospital capacity.
Key Facts
- Measles cases have reached their highest level in 35 years, surpassing the 2019 outbreak that previously held the post-elimination record with 1,282 cases.
- Dr. Jay Bhattacharya, who assumed the role of NIH Director in 2025, made the statement to CBS News on Sunday, August 9, 2026.
- The CDC has confirmed outbreaks in at least five states, with the largest clusters reported in Texas, Ohio, and New York.
- Childhood vaccination rates for MMR (measles-mumps-rubella) have fallen to 91.2% nationally, below the 95% herd immunity threshold required to prevent sustained transmission.
- The World Health Organization reported that global measles cases rose by 20% in 2025, with the U.S. now mirroring that trend.
- Hospitalization rates for current measles cases are running at approximately 1 in 5, consistent with the virus's known severity in unvaccinated populations.
- Bhattacharya's statement marks a notable departure from his previous academic work, which focused heavily on COVID-19 lockdowns and questioned certain public health mandates.
Breaking It Down
The significance of Bhattacharya's statement cannot be overstated. He is not merely a federal health official; he is a figure who built his public reputation as a skeptic of sweeping public health interventions. His 2020 co-authored Great Barrington Declaration argued against lockdowns and advocated for "focused protection" of vulnerable populations. For that position, he was celebrated by vaccine-skeptic communities and criticized by mainstream epidemiologists. Now, as NIH Director, his explicit endorsement of vaccines carries weight precisely because he has historically been viewed as a counterweight to establishment health orthodoxy.
The 3.8 percentage-point drop in MMR vaccination rates — from the 95% threshold down to 91.2% — represents roughly 1.2 million children under the age of five who are currently unprotected against measles.
That gap is not abstract. Measles is one of the most contagious viruses known to medicine, with an R0 of 12 to 18. In a fully susceptible population, a single infected child can infect more than a dozen others. The current outbreak trajectory suggests that the U.S. has crossed a critical epidemiological threshold: the virus is no longer being imported and contained; it is now circulating domestically in communities with concentrated vaccine refusal. Bhattacharya's statement, while scientifically unremarkable, is politically significant because it signals that the NIH is willing to publicly re-assert vaccine efficacy even amidst a polarized political environment where vaccine mandates remain contentious.
There is also a timing element. The statement arrives just ahead of the fall school season, when many states enforce vaccination requirements for enrollment. Public health officials are hoping that federal leadership can influence hesitant parents. However, Bhattacharya's endorsement stops short of advocating for mandates, leaving a critical policy gap. The question is no longer whether the science supports vaccines — it does, unequivocally — but whether the federal government will move beyond messaging to enforceable action.
What Comes Next
- CDC's September Morbidity and Mortality Weekly Report — expected in early September 2026, this report will provide updated case counts and likely trigger formal outbreak declarations in additional states.
- State legislative sessions — at least six state legislatures (including Texas, Ohio, and Florida) are expected to introduce bills in the fall addressing school vaccine exemptions, ranging from tightening non-medical exemptions to eliminating them entirely.
- FDA advisory committee meeting on MMR booster dosing — scheduled for October 14, 2026, this meeting will consider whether a third MMR dose should be recommended for children in high-outbreak counties.
- Bhattacharya's upcoming congressional testimony — the Senate Health Committee has requested his appearance for September 22, 2026, to discuss NIH's response to the outbreak and federal vaccine policy.
The Bigger Picture
This outbreak is unfolding against the backdrop of two converging trends: vaccine hesitancy and public health politicization. The anti-vaccine movement, once fringe, has gained mainstream political traction since the COVID-19 pandemic, with several high-profile politicians and influencers amplifying skepticism about all vaccines, not just COVID shots. Measles has become the first casualty of this broader distrust.
The second trend is the erosion of federal public health authority. The NIH, CDC, and FDA have all faced credibility challenges since 2020, and the current administration has been reluctant to issue strong federal guidance. Bhattacharya's statement is a step toward rebuilding that authority, but it remains to be seen whether trust can be restored before the outbreak peaks. Historically, measles outbreaks in the U.S. have been contained within one transmission season; this one has persisted for over eight months, suggesting that traditional containment measures may no longer suffice.
Key Takeaways
- Bhattacharya's Endorsement: The NIH Director's public "I trust the science" statement is a pivotal moment, signaling federal health leadership is willing to re-engage on vaccine advocacy despite political headwinds.
- Epidemiological Threshold Breached: With MMR vaccination at 91.2%, the U.S. has fallen below the 95% herd immunity threshold, leaving an estimated 1.2 million young children vulnerable.
- Outbreak Scale: Measles cases are at a 35-year high, with sustained domestic transmission now occurring across at least five states — no longer just imported cases.
- Policy Crossroads: The coming weeks will determine whether the federal response remains limited to messaging or expands to include regulatory action, such as revised booster recommendations or federal support for state-level mandate enforcement.
